# Immune Monitoring on Sipuleucel-T

> **NCT02237170** · — · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 36 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02237170
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02237170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02237170, "Immune Monitoring on Sipuleucel-T". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02237170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*